Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Psychometric Analyses to Inform Item Reduction and Evaluate Sensitivity of the Early Mobility Impairment Questionnaire for Multiple Sclerosis.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
Papers: 23 Oct 2015 - 30 Oct 2015
Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Papers: 22 May 2015 - 29 May 2015
Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.
Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Papers: 10 Oct 2015 - 17 Oct 2015
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Papers: 14 Aug 2015 - 21 Aug 2015
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
Papers: 8 May 2015 - 15 May 2015
Olfactory dysfunction in patients with multiple sclerosis.
Histamine and Immune Biomarkers in CNS Disorders.
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
European Multiple Sclerosis Platform 2016 Spring Conference
Papers: 31 Jul 2014 - 7 Aug 2014
Papers: 22 Dec 2015 - 29 Dec 2015
Papers: 31 Jul 2014 - 7 Aug 2014
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »